HEMOLISIS SOLUTION MINDRAY. - COFEPRIS Registration 2173R2021 SSA
Access comprehensive regulatory information for HEMOLISIS SOLUTION MINDRAY. (MINDRAY HEMOLYSIS SOLUTION.) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 2173R2021 SSA and manufactured by MINDRAY MEDICALMÉXICO, S. DE R.L. DEC.V.. The device was registered on December 15, 2021.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
HEMOLISIS SOLUTION MINDRAY SE UTILIZACON EL ANALIZADOR AUTOMÁTICO DEGLICOHEMOGLOBINAMINDRAYH50/H50P.SEUTILIZA PARA EL TRATAMIENTO PREVIO DELAS MUESTRAS DE SANGRE ANTES DELANÁLISIS DE HBA1C. AGENTE DEDIAGNÓSTICOPARAUSOINVITRO. PARAUSOEXCLUSIVO EN LABORATORIOS CLÍNICOS ODE GABINETE.
HEMOLYSIS SOLUTION MINDRAY IS USED WITH THE AUTOMATIC ANALYZER DEGLYCOHEMOGLOBINAMINDRAYH50/H50P. IT IS USED FOR PRE-TREATMENT OF BLOOD SAMPLES PRIOR TO HBA1C ANALYSIS. DIAGNOSTIC AGENTFORUSEINVITRO. FOR EXCLUSIVE USE IN CLINICAL LABORATORIES OR CABINET.